(Q39448680)

12 September 2017

title

Clinical significance of steroid and xenobiotic receptor and its targeted gene CYP3A4 in human prostate cancer (English)

1 reference

12 September 2017

1 reference

13

Yukio Homma

1 reference

12 September 2017

1

Tetsuya Fujimura

1 reference

12 September 2017

Satoru Takahashi

2

1 reference

12 September 2017

Tomohiko Urano

3

1 reference

12 September 2017

Toshiya Tanaka

4

1 reference

12 September 2017

Weiguang Zhang

5

1 reference

12 September 2017

Kotaro Azuma

6

1 reference

12 September 2017

Kenich Takayama

7

1 reference

12 September 2017

Daisuke Obinata

8

1 reference

12 September 2017

Taro Murata

9

1 reference

12 September 2017

Kuniko Horie-Inoue

10

1 reference

12 September 2017

Tatsuhiko Kodama

11

1 reference

12 September 2017

Yasuyoshi Ouchi

12

1 reference

12 September 2017

Satoshi Inoue

14

1 reference

12 September 2017

publication date

27 November 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

103

1 reference

12 September 2017

issue

2

1 reference

12 September 2017

page(s)

176-180

1 reference

Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

Genomic strategy for targeting therapy in castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

The adrenal androgen androstenediol is present in prostate cancer tissue after androgen deprivation therapy and activates mutated androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

Cytochrome P450 2B6 is a growth-inhibitory and prognostic factor for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6 beta-hydroxylase cytochrome P-450 enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

The identification and characterization of a new c1903 steroid metabolite in the eat ventral prostate: 5α-androstane-3β, 6α, 17β-triol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

Characterization of two new enzymatic activities of the rat ventral prostate: 5 alpha-androstane-3 beta, 17 beta-diol 6 alpha-hydroxylase and 5 alpha-androstane-3 beta, 17 beta-diol 7 alpha-hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

Expression of cytochrome P450 3A4 and its clinical significance in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

SXR, a novel steroid and xenobiotic-sensing nuclear receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

Activation of the steroid and xenobiotic receptor, SXR, induces apoptosis in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

Pregnane X receptor suppresses proliferation and tumourigenicity of colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

Steroid and xenobiotic receptor SXR mediates vitamin K2-activated transcription of extracellular matrix-related genes and collagen accumulation in osteoblastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

The generation of monoclonal antibodies against human peroxisome proliferator-activated receptors (PPARs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

Differential expression of estrogen-related receptors beta and gamma (ERRbeta and ERRgamma) and their clinical significance in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

Pregnane X receptor as a therapeutic target to inhibit androgen activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

Endocrine treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02143.X

10.1111/J.1349-7006.2011.02143.X

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference